Track Amedisys, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Amedisys, Inc. AMED Open Amedisys, Inc. in new tab

100.99 USD
P/E
39.30
EPS
2.57
P/B
2.69
ROE
6.67
Beta
0.90
Target Price
97.38 USD
Loading chart...
Key Metrics
Earnings dateOct. 22, 2024
P/E39.30
EPS2.57
Book Value37.48
Price to Book2.69
Debt/Equity35.34
% Insiders1.951%
Growth
Revenue Growth0.05%
Earnings Growth-0.14%
Estimates
Forward P/E19.76
Forward EPS5.11
Target Mean Price97.38

DCF Valuation

Tweak assumptions to recompute fair value for Amedisys, Inc. (AMED)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Amedisys, Inc. Logo Amedisys, Inc. Analysis (AMED)

United States Health Care Official Website Stock

Is Amedisys, Inc. a good investment? Amedisys, Inc. (AMED) is currently trading at 100.99 USD. Market analysts have a consensus price target of 97.38 USD. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 39.30. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Amedisys, Inc. is expected to release its next earnings report on Oct. 22, 2024. The market consensus estimate for Forward EPS is 5.11.

Investor FAQ

Does Amedisys, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Amedisys, Inc.?

Amedisys, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Oct. 22, 2024. The company currently has a trailing EPS of 2.57.

Company Profile

Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was formerly known as Analytical Nursing Management Corp. and changed its name to Amedisys, Inc. in August 1995. The company was founded in 1982 and is headquartered in Baton Rouge, Louisiana with an additional office in Nashville, Tennessee. As of August 14, 2025, Amedisys, Inc. operates as a subsidiary of Optum, Inc.

Exchange Ticker
MEX (Mexico) AMED.MX
NMS (United States) AMED
FRA (Germany) ADY.F

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Dec. 5, 2006 1.330000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion